189 related articles for article (PubMed ID: 16571819)
21. Lymphomas and high-level expression of murine leukemia viruses in CFW mice.
Taddesse-Heath L; Chattopadhyay SK; Dillehay DL; Lander MR; Nagashfar Z; Morse HC; Hartley JW
J Virol; 2000 Aug; 74(15):6832-7. PubMed ID: 10888622
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
[TBL] [Abstract][Full Text] [Related]
23. Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.
Granger SW; Bundy LM; Fan H
J Virol; 1999 Sep; 73(9):7175-84. PubMed ID: 10438804
[TBL] [Abstract][Full Text] [Related]
24. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
25. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
[TBL] [Abstract][Full Text] [Related]
26. Studies on the pathogenesis and mechanism of hematologic diversification by re-isolation of the myeloid leukemia virus (Graffi).
Fey F
Acta Haematol; 1969; 42(2):65-75. PubMed ID: 4311598
[No Abstract] [Full Text] [Related]
27. An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo.
Browne EP
J Virol; 2015 Jan; 89(1):155-64. PubMed ID: 25320301
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus.
Fischinger PJ; Dunlop NM; Robey WG
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):241-51. PubMed ID: 2982768
[TBL] [Abstract][Full Text] [Related]
29. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
[TBL] [Abstract][Full Text] [Related]
30. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
31. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
32. Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector.
Kitagawa M; Aizawa S; Kamisaku H; Hirokawa K; Ikeda H
Exp Hematol; 1999 Feb; 27(2):234-41. PubMed ID: 10029162
[TBL] [Abstract][Full Text] [Related]
33. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.
Hartley JW; Evans LH; Green KY; Naghashfar Z; Macias AR; Zerfas PM; Ward JM
Retrovirology; 2008 Jan; 5():1. PubMed ID: 18177500
[TBL] [Abstract][Full Text] [Related]
34. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
Hanecak R; Pattengale PK; Fan H
J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
[TBL] [Abstract][Full Text] [Related]
35. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
36. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
Cloyd MW; Evans LH
J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
[TBL] [Abstract][Full Text] [Related]
37. New class of leukemogenic ecotropic recombinant murine leukemia virus isolated from radiation-induced thymomas of C57BL/6 mice.
Rassart E; Sankar-Mistry P; Lemay G; DesGroseillers L; Jolicoeur P
J Virol; 1983 Feb; 45(2):565-75. PubMed ID: 6300420
[TBL] [Abstract][Full Text] [Related]
38. Histologic and cell surface antigen studies of hematopoietic tumors induced by Cas-Br-M murine leukemia virus.
Fredrickson TN; Langdon WY; Hoffman PM; Hartley JW; Morse HC
J Natl Cancer Inst; 1984 Feb; 72(2):447-54. PubMed ID: 6319793
[TBL] [Abstract][Full Text] [Related]
39. Host range conversion of murine leukemia virus resulting from recombination with endogenous virus.
Kawana A; Iwamoto A; Odawara T; Yoshikura H
Arch Virol; 1997; 142(1):139-49. PubMed ID: 9155878
[TBL] [Abstract][Full Text] [Related]
40. Large-scale identification of disease genes involved in acute myeloid leukemia.
Erkeland SJ; Valkhof M; Heijmans-Antonissen C; van Hoven-Beijen A; Delwel R; Hermans MH; Touw IP
J Virol; 2004 Feb; 78(4):1971-80. PubMed ID: 14747562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
